ProQR (PRQRN) Stock Forecast & Price Target

1 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

PRQRN Analyst Ratings

Strong Buy

4 Buy

0 Hold

0 Sell

Based on 4 analysts giving stock ratings to

ProQR

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

PRQRN Stock 12 Month Forecast

Average Price Target

$154.02

▲(419.80% Upside)

Based on 4 Wall Street analysts offering 12 month price targets for ProQR in the last 3 months. The average price target is $154.02 with a high forecast of $168.02 and a low forecast of $149.35. The average price target represents a 419.80% change from the last price of $29.63.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"28":"$28","169":"$169","63.25":"$63.3","98.5":"$98.5","133.75":"$133.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":168.01702569,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$168.02</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":154.0156068825,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$154.02</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":149.34846728,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$149.35</span>\n  </div></div>","useHTML":true}}],"tickPositions":[28,63.25,98.5,133.75,169],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,29.63,40.275155822307696,50.92031164461538,61.56546746692308,72.21062328923077,82.85577911153847,93.50093493384615,104.14609075615385,114.79124657846154,125.43640240076923,136.08155822307694,146.72671404538463,157.3718698676923,{"y":168.01702569,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,29.63,39.19812360634616,48.766247212692306,58.33437081903847,67.90249442538462,77.47061803173078,87.03874163807693,96.60686524442309,106.17498885076924,115.74311245711539,125.31123606346155,134.8793596698077,144.44748327615386,{"y":154.0156068825,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,29.63,38.83911286769231,48.04822573538462,57.257338603076924,66.46645147076923,75.67556433846154,84.88467720615385,94.09379007384615,103.30290294153846,112.51201580923077,121.72112867692309,130.9302415446154,140.1393544123077,{"y":149.34846728,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":36,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":36,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":36,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":36,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":36,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":36,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":36,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":36,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":36,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":35,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":29,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":29.63,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":29.63,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$168.02

Average Price Target$154.02

Lowest Price Target$149.35

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Ananda Ghosh

H.C. Wainwright

$224.02→$149.35

Buy

404.04%

Upside

Reiterated

10/01/26

Analysts Offer Insights on Healthcare Companies: ProQR (NASDAQ: PRQR) and Sagimet Biosciences, Inc. Class A (NASDAQ: SGMT)

Alec Stranahan

Bank of America Securities

$149.35

Buy

404.04%

Upside

Reiterated

09/30/26

Analyst Reiterates Buy Rating and Unchanged $8 Price Target on ProQR Amid Growing Confidence in NTCP Strategy and Upcoming Catalysts

Steven Seedhouse

Cantor Fitzgerald

$149.35

Buy

404.04%

Upside

Reiterated

08/14/26

Cantor Fitzgerald Keeps Their Buy Rating on ProQR (PRQR)

Kostas Biliouris

Oppenheimer

$168.02

Buy

467.05%

Upside

Reiterated

08/14/26

Oppenheimer Keeps Their Buy Rating on ProQR (PRQR)

Catherine Novack

JonesTrading

$205.35→$186.69

Buy

530.06%

Upside

Reiterated

06/26/26

ProQR Therapeutics price target lowered to $10 from $11 at JonesResearchProQR Therapeutics price target lowered to $10 from $11 at JonesResearch

Ryan Deschner

Raymond James

$261.36→$186.69

Buy

530.06%

Upside

Reiterated

06/26/26

ProQR Therapeutics price target lowered to $10 from $14 at Raymond JamesProQR Therapeutics price target lowered to $10 from $14 at Raymond James

Keay Nakae

Chardan Capital

$74.67→$56.01

Buy

89.02%

Upside

Reiterated

06/25/26

ProQR Therapeutics price target lowered to $3 from $4 at ChardanProQR Therapeutics price target lowered to $3 from $4 at Chardan

Jonathan Wolleben

Citizens JMP

$149.35

Buy

404.04%

Upside

Reiterated

03/12/26

Gavin Clark-Gartner

Evercore ISI

$93.34

Buy

215.03%

Upside

Reiterated

12/17/25

Evercore ISI Remains a Buy on ProQR (PRQR)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Ananda Ghosh

H.C. Wainwright

$224.02→$149.35

Buy

404.04%

Upside

Reiterated

10/01/26

Analysts Offer Insights on Healthcare Companies: ProQR (NASDAQ: PRQR) and Sagimet Biosciences, Inc. Class A (NASDAQ: SGMT)

Alec Stranahan

Bank of America Securities

$149.35

Buy

404.04%

Upside

Reiterated

09/30/26

Analyst Reiterates Buy Rating and Unchanged $8 Price Target on ProQR Amid Growing Confidence in NTCP Strategy and Upcoming Catalysts

Steven Seedhouse

Cantor Fitzgerald

$149.35

Buy

404.04%

Upside

Reiterated

08/14/26

Cantor Fitzgerald Keeps Their Buy Rating on ProQR (PRQR)

Kostas Biliouris

Oppenheimer

$168.02

Buy

467.05%

Upside

Reiterated

08/14/26

Oppenheimer Keeps Their Buy Rating on ProQR (PRQR)

Catherine Novack

JonesTrading

$205.35→$186.69

Buy

530.06%

Upside

Reiterated

06/26/26

ProQR Therapeutics price target lowered to $10 from $11 at JonesResearchProQR Therapeutics price target lowered to $10 from $11 at JonesResearch

Ryan Deschner

Raymond James

$261.36→$186.69

Buy

530.06%

Upside

Reiterated

06/26/26

ProQR Therapeutics price target lowered to $10 from $14 at Raymond JamesProQR Therapeutics price target lowered to $10 from $14 at Raymond James

Keay Nakae

Chardan Capital

$74.67→$56.01

Buy

89.02%

Upside

Reiterated

06/25/26

ProQR Therapeutics price target lowered to $3 from $4 at ChardanProQR Therapeutics price target lowered to $3 from $4 at Chardan

Jonathan Wolleben

Citizens JMP

$149.35

Buy

404.04%

Upside

Reiterated

03/12/26

Gavin Clark-Gartner

Evercore ISI

$93.34

Buy

215.03%

Upside

Reiterated

12/17/25

Evercore ISI Remains a Buy on ProQR (PRQR)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

AORTArtivion

MDWDMediwound

IMUXImmunic

RZLTRezolute

DFTXDefinium Therapeutics

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering ProQR

3 Months

Jonathan WollebenCitizens JMP

Success Rate

9/18 ratings generated profit

Average Return

+1.51%

Copying Jonathan Wolleben's trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +1.51% per trade.

1 Year

Jonathan WollebenCitizens JMP

Success Rate

10/18 ratings generated profit

Average Return

+8.84%

Copying Jonathan Wolleben's trades and holding each position for 1 Year would result in 55.56% of your transactions generating a profit, with an average return of +8.84% per trade.

2 Years

Jonathan WollebenCitizens JMP

Success Rate

5/18 ratings generated profit

Average Return

-10.77%

Copying Jonathan Wolleben's trades and holding each position for 2 Years would result in 27.78% of your transactions generating a profit, with an average return of -10.77% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

PRQRN Analyst Recommendation Trends

Rating

Jun 26

Jul 26

Aug 26

Sep 26

Oct 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, PRQRN has received 7 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. PRQRN average Analyst price target in the past 3 months is 154.02.

Each month's total comprises the sum of three months' worth of ratings.

PRQRN Financial Forecast

PRQRN Earnings Forecast

Next quarter’s earnings estimate for PRQRN is -$2.13 with a range of -$3.22 to -$1.47. The previous quarter’s EPS was -$1.68. PRQRN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year PRQRN has Performed in-line its overall industry.

PRQRN Sales Forecast

Next quarter’s sales forecast for PRQRN is $79.93M with a range of $0.00 to $105.26M. The previous quarter’s sales results were $191.33M. PRQRN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year PRQRN has Performed in-line its overall industry.

PRQRN Stock Forecast FAQ

What is MX:PRQRN’s average 12-month price target, according to analysts?

Based on analyst ratings, ProQR’s 12-month average price target is 154.02.

What is MX:PRQRN’s upside potential, based on the analysts’ average price target?

ProQR has 419.80% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is ProQR a Buy, Sell or Hold?

ProQR has a consensus rating of Strong Buy, which is based on 4 buy ratings, 0 hold ratings and 0 sell ratings.

What is ProQR’s share price target?

The average share price target for ProQR is 154.02. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is $168.02 ,and the lowest forecast is $149.35. The average share price target represents 419.80% Increase from the current price of $29.63.

What do analysts say about ProQR?

ProQR’s analyst rating consensus is a Strong Buy. This is based on the ratings of 4 Wall Streets Analysts.

How can I buy shares of ProQR?

To buy shares of MX:PRQRN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

ProQR (PRQRN) Stock Forecast & Price Target

PRQRN Analyst Ratings

PRQRN Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering ProQR

PRQRN Analyst Recommendation Trends

PRQRN Financial Forecast

PRQRN Earnings Forecast

PRQRN Sales Forecast

PRQRN Stock Forecast FAQ

Detailed List of Analyst Forecasts